{"id":344672,"date":"2025-08-24T13:47:05","date_gmt":"2025-08-24T13:47:05","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-biohaven\/"},"modified":"2025-08-24T13:47:05","modified_gmt":"2025-08-24T13:47:05","slug":"how-to-buy-biohaven","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/","title":{"rendered":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Biohaven Ltd. (BHVN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu n\u00f6robilim biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. Ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in g\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Biohaven Ltd. (BHVN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu n\u00f6robilim biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. Ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in g\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin."},"intro":"Keskin n\u00f6robilim alan\u0131na yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Biohaven Ltd. (BHVN), Parkinson, migren ve n\u00f6rolojik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler geli\u015ftiren biyoteknoloji inovasyonunun \u00f6nc\u00fcs\u00fcd\u00fcr. Bu \u015firket, t\u0131bb\u0131n gelece\u011fine a\u00e7\u0131lan kap\u0131n\u0131z olabilir, ancak ak\u0131ll\u0131 yat\u0131r\u0131m yapmak i\u00e7in hem bilimi hem de hisse senedi dinamiklerini anlamak gerekir. Portf\u00f6y\u00fcn\u00fcze BHVN eklemek i\u00e7in bilmeniz gereken her \u015feyi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin n\u00f6robilim alan\u0131na yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Biohaven Ltd. (BHVN), Parkinson, migren ve n\u00f6rolojik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler geli\u015ftiren biyoteknoloji inovasyonunun \u00f6nc\u00fcs\u00fcd\u00fcr. Bu \u015firket, t\u0131bb\u0131n gelece\u011fine a\u00e7\u0131lan kap\u0131n\u0131z olabilir, ancak ak\u0131ll\u0131 yat\u0131r\u0131m yapmak i\u00e7in hem bilimi hem de hisse senedi dinamiklerini anlamak gerekir. Portf\u00f6y\u00fcn\u00fcze BHVN eklemek i\u00e7in bilmeniz gereken her \u015feyi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Biohaven Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>24 A\u011fustos 2025 itibar\u0131yla Biohaven Ltd. (BHVN), NYSE'de <strong>14,68 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik bir tarih\u2014Biohaven'in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu \u00e7eyreklik a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 BHVN Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>11 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>15,29 $<\/td><td>-%4,0 (1 hafta)<\/td><\/tr> <tr><td>29 May 2025<\/td><td>Parkinson Deneme Ba\u015flang\u0131c\u0131<\/td><td>16,50 $<\/td><td>+%8,2 (3 g\u00fcn)<\/td><\/tr> <tr><td>12 \u015eub 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>18,20 $<\/td><td>-%12,1 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>5 Kas 2024<\/td><td>Klinik Veri Yay\u0131n\u0131<\/td><td>22,40 $<\/td><td>+%6,3 (pozitif sonu\u00e7lar)<\/td><\/tr> <tr><td>9 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>25,10 $<\/td><td>-%8,9 (d\u00fczenleyici endi\u015feler)<\/td><\/tr> <tr><td>15 May 2024<\/td><td>FDA Ba\u015fvurusu<\/td><td>28,60 $<\/td><td>+%15,2 (yat\u0131r\u0131mc\u0131 iyimserli\u011fi)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik deneme haberleri (May\u0131s 2025 gibi) genellikle fiyatlar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131r\u0131rken, kazan\u00e7 hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131 keskin d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar. Hisse senedi, d\u00fczenleyici geli\u015fmelere ve deneme sonu\u00e7lar\u0131na kar\u015f\u0131 a\u015f\u0131r\u0131 duyarl\u0131l\u0131k g\u00f6sterir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>Biohaven hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%42<\/strong> oran\u0131nda dramatik bir volatilite ya\u015fad\u0131:<\/p> <p><strong>\u015eubat<\/strong>: 25,40 $ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 iyimserlik)<br> <strong>Mart<\/strong>: 21,80 $ (FDA endi\u015feleri ortaya \u00e7\u0131kt\u0131)<br> <strong>May\u0131s<\/strong>: 18,90 $ (Parkinson deneme duyurusu destek sa\u011flad\u0131)<br> <strong>Temmuz<\/strong>: 16,20 $ (yaz d\u00f6nemi i\u015flem durgunlu\u011fu)<br> <strong>A\u011fustos<\/strong>: 14,68 $ (2. \u00e7eyrek sonu\u00e7lar\u0131 sonras\u0131 mevcut seviyeler)<\/p> <p><strong>D\u00fc\u015f\u00fc\u015f\u00fcn nedenleri?<\/strong><\/p> <ul> <li>\u0130la\u00e7 onaylar\u0131yla ilgili d\u00fczenleyici belirsizlik<\/li> <li>Klinik a\u015famadaki biyoteknoloji \u015firketlerine \u00f6zg\u00fc y\u00fcksek nakit t\u00fcketimi<\/li> <li>Spek\u00fclatif biyoteknoloji hisselerinden piyasa rotasyonu<\/li> <li>\u00d6nceki FDA engelleri nedeniyle yat\u0131r\u0131mc\u0131 temkinlili\u011fi<\/li> <\/ul> <p>Ancak, Parkinson denemesindeki ilerleme temel destek sa\u011flayarak son momentumun istikrar i\u015faretleri g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2> <p><strong>2025 (Y\u0131l Sonu)<\/strong>: 18-22 $ (potansiyel pozitif klinik veri) \u2192 <strong>UZUN VADEL\u0130 ALIM<\/strong><br> <strong>2026<\/strong>: 26-32 $ (Parkinson denemesi Faz 2 sonu\u00e7lar\u0131 bekleniyor)<br> <strong>2028<\/strong>: 45-60 $ (pipeline\u2019dan potansiyel ilk ticari onay)<br> <strong>2030<\/strong>: 75-100+ $ (birden fazla onayl\u0131 terapi gelirleri art\u0131racak)<\/p> <p><strong>Sonu\u00e7<\/strong>: <strong>Risk tolerans\u0131 y\u00fcksek uzun vadeli yat\u0131r\u0131mc\u0131lar<\/strong> i\u00e7in ideal. Mevcut fiyatlar b\u00fcy\u00fck kataliz\u00f6rler \u00f6ncesi potansiyel giri\u015f noktalar\u0131n\u0131 temsil ediyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7lar\u0131n %90\u2019\u0131 ge\u00e7 a\u015fama denemelerde ba\u015far\u0131s\u0131z olur<\/li> <li><strong>D\u00fczenleyici reddi<\/strong>: FDA kararlar\u0131 de\u011ferin %50\u2019sinden fazlas\u0131n\u0131 an\u0131nda silebilir<\/li> <li><strong>Nakit t\u00fcketimi<\/strong>: 408,2 milyon $ nakit rezervi (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-reports-second-quarter-2025-financial-results-and-recent-business-developments-302526204.html\">2. \u00c7eyrek 2025 Raporu<\/a>) yenilenmeye ihtiya\u00e7 duyabilir<\/li> <li><strong>Y\u00fcksek volatilite<\/strong>: %9,46 volatilite oran\u0131 ve 1,49 beta de\u011feri<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Parkinson at\u0131l\u0131m\u0131<\/strong>: Faz 2\/3 denemesine ilk hasta kaydedildi (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-enrolls-first-patient-into-phase-23-trial-in-early-parkinsons-disease-targeting-neuroinflammation-with-novel-brain-penetrant-tyk2jak1-inhibitor-302467788.html\">May\u0131s 2025<\/a>)<\/li> <li><strong>G\u00fc\u00e7l\u00fc analist deste\u011fi<\/strong>: 13 analist \"G\u00fc\u00e7l\u00fc Al\" derecesi verdi, ortalama hedef 54,62 $<\/li> <li><strong>Yenilik\u00e7i pipeline<\/strong>: Kv7 mod\u00fclasyonu ve TYK2\/JAK1 inhibit\u00f6rleri dahil birden fazla platform<\/li> <li><strong>Kan\u0131tlanm\u0131\u015f ba\u015far\u0131<\/strong>: Nurtec ODT migren tedavisinde ba\u015far\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in birka\u00e7 ay boyunca k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 11 Kas\u0131m kazan\u00e7lar\u0131n\u0131 izleyin<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: Dengeli bir portf\u00f6y i\u00e7in stabil temett\u00fc hisseleri ve endeks fonlar\u0131 ile dengeleyin<\/li> <\/ol> <p>Espiri: \"BHVN ticareti klinik denemeleri izlemek gibidir\u2014g\u00fc\u00e7l\u00fc sinirlere ihtiyac\u0131n\u0131z var ve Faz 1 sonu\u00e7lar\u0131na asla t\u00fcm sermayenizi yat\u0131rmay\u0131n!\"<\/p> <h2>\u2705 Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NYSE listeli hisseler ve par\u00e7al\u0131 hisse sunan bir platform se\u00e7in<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"BHVN\" aramas\u0131 yap\u0131n<\/td><td>Do\u011fru sonu\u00e7lar i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014i\u015flem de\u011ferinin %1\u2019inden az olmas\u0131na dikkat edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmel ama d\u00fc\u015f\u00fck riskli<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong>\u2014sadece bir kimlik belgesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>\u2014k\u00e2rlar\u0131n\u0131za birden fazla uygun y\u00f6ntemle eri\u015fin<\/li> <li><strong>E\u011fitim kaynaklar\u0131<\/strong>\u2014Pocket Option blogu ile i\u015flem yaparken \u00f6\u011frenin<\/li> <\/ul> <h2>\ud83c\udf0d 2025\u2019te Biohaven: N\u00f6robilim \u0130novasyon Lideri<\/h2> <p>Biohaven, n\u00f6robilim biyoteknoloji alan\u0131nda en yenilik\u00e7i portf\u00f6ylerden biriyle sekt\u00f6rde hakimiyet kuruyor. Kan\u0131tlanm\u0131\u015f migren tedavileri Nurtec ODT ve Zavzpret\u2019in \u00f6tesinde, Parkinson, n\u00f6roenflamasyon ve nadir n\u00f6rolojik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler geli\u015ftiriyor. \u015eirket, 2025 Amerikan N\u00f6roloji Akademisi toplant\u0131s\u0131nda <strong>13 ara\u015ft\u0131rma \u00f6zeti<\/strong> sundu; Kv7 mod\u00fclasyonu, ekstrasel\u00fcler protein degradasyonu ve TRPM3 antagonizmas\u0131 gibi bir\u00e7ok ileri platformda bilimsel derinli\u011fini g\u00f6sterdi.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: Biohaven\u2019in Parkinson denemesi, beyin penetran TYK2\/JAK1 inhibit\u00f6r\u00fc ile n\u00f6roenflamasyonu hedefleyen ilk klinik \u00e7al\u0131\u015fma olup, d\u00fcnya \u00e7ap\u0131nda 10 milyondan fazla hasta i\u00e7in tedavide devrim yaratabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Biohaven Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>24 A\u011fustos 2025 itibar\u0131yla Biohaven Ltd. (BHVN), NYSE&#8217;de <strong>14,68 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>11 Kas\u0131m 2025<\/strong> kesinlikle kritik bir tarih\u2014Biohaven&#8217;in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu \u00e7eyreklik a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 BHVN Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>11 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>15,29 $<\/td>\n<td>-%4,0 (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>29 May 2025<\/td>\n<td>Parkinson Deneme Ba\u015flang\u0131c\u0131<\/td>\n<td>16,50 $<\/td>\n<td>+%8,2 (3 g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eub 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>18,20 $<\/td>\n<td>-%12,1 (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>5 Kas 2024<\/td>\n<td>Klinik Veri Yay\u0131n\u0131<\/td>\n<td>22,40 $<\/td>\n<td>+%6,3 (pozitif sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>9 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>25,10 $<\/td>\n<td>-%8,9 (d\u00fczenleyici endi\u015feler)<\/td>\n<\/tr>\n<tr>\n<td>15 May 2024<\/td>\n<td>FDA Ba\u015fvurusu<\/td>\n<td>28,60 $<\/td>\n<td>+%15,2 (yat\u0131r\u0131mc\u0131 iyimserli\u011fi)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik deneme haberleri (May\u0131s 2025 gibi) genellikle fiyatlar\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131r\u0131rken, kazan\u00e7 hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131 keskin d\u00fc\u015f\u00fc\u015flere yol a\u00e7ar. Hisse senedi, d\u00fczenleyici geli\u015fmelere ve deneme sonu\u00e7lar\u0131na kar\u015f\u0131 a\u015f\u0131r\u0131 duyarl\u0131l\u0131k g\u00f6sterir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>Biohaven hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%42<\/strong> oran\u0131nda dramatik bir volatilite ya\u015fad\u0131:<\/p>\n<p><strong>\u015eubat<\/strong>: 25,40 $ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 iyimserlik)<br \/> <strong>Mart<\/strong>: 21,80 $ (FDA endi\u015feleri ortaya \u00e7\u0131kt\u0131)<br \/> <strong>May\u0131s<\/strong>: 18,90 $ (Parkinson deneme duyurusu destek sa\u011flad\u0131)<br \/> <strong>Temmuz<\/strong>: 16,20 $ (yaz d\u00f6nemi i\u015flem durgunlu\u011fu)<br \/> <strong>A\u011fustos<\/strong>: 14,68 $ (2. \u00e7eyrek sonu\u00e7lar\u0131 sonras\u0131 mevcut seviyeler)<\/p>\n<p><strong>D\u00fc\u015f\u00fc\u015f\u00fcn nedenleri?<\/strong><\/p>\n<ul>\n<li>\u0130la\u00e7 onaylar\u0131yla ilgili d\u00fczenleyici belirsizlik<\/li>\n<li>Klinik a\u015famadaki biyoteknoloji \u015firketlerine \u00f6zg\u00fc y\u00fcksek nakit t\u00fcketimi<\/li>\n<li>Spek\u00fclatif biyoteknoloji hisselerinden piyasa rotasyonu<\/li>\n<li>\u00d6nceki FDA engelleri nedeniyle yat\u0131r\u0131mc\u0131 temkinlili\u011fi<\/li>\n<\/ul>\n<p>Ancak, Parkinson denemesindeki ilerleme temel destek sa\u011flayarak son momentumun istikrar i\u015faretleri g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2>\n<p><strong>2025 (Y\u0131l Sonu)<\/strong>: 18-22 $ (potansiyel pozitif klinik veri) \u2192 <strong>UZUN VADEL\u0130 ALIM<\/strong><br \/> <strong>2026<\/strong>: 26-32 $ (Parkinson denemesi Faz 2 sonu\u00e7lar\u0131 bekleniyor)<br \/> <strong>2028<\/strong>: 45-60 $ (pipeline\u2019dan potansiyel ilk ticari onay)<br \/> <strong>2030<\/strong>: 75-100+ $ (birden fazla onayl\u0131 terapi gelirleri art\u0131racak)<\/p>\n<p><strong>Sonu\u00e7<\/strong>: <strong>Risk tolerans\u0131 y\u00fcksek uzun vadeli yat\u0131r\u0131mc\u0131lar<\/strong> i\u00e7in ideal. Mevcut fiyatlar b\u00fcy\u00fck kataliz\u00f6rler \u00f6ncesi potansiyel giri\u015f noktalar\u0131n\u0131 temsil ediyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: \u0130la\u00e7lar\u0131n %90\u2019\u0131 ge\u00e7 a\u015fama denemelerde ba\u015far\u0131s\u0131z olur<\/li>\n<li><strong>D\u00fczenleyici reddi<\/strong>: FDA kararlar\u0131 de\u011ferin %50\u2019sinden fazlas\u0131n\u0131 an\u0131nda silebilir<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong>: 408,2 milyon $ nakit rezervi (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-reports-second-quarter-2025-financial-results-and-recent-business-developments-302526204.html\">2. \u00c7eyrek 2025 Raporu<\/a>) yenilenmeye ihtiya\u00e7 duyabilir<\/li>\n<li><strong>Y\u00fcksek volatilite<\/strong>: %9,46 volatilite oran\u0131 ve 1,49 beta de\u011feri<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Parkinson at\u0131l\u0131m\u0131<\/strong>: Faz 2\/3 denemesine ilk hasta kaydedildi (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-enrolls-first-patient-into-phase-23-trial-in-early-parkinsons-disease-targeting-neuroinflammation-with-novel-brain-penetrant-tyk2jak1-inhibitor-302467788.html\">May\u0131s 2025<\/a>)<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc analist deste\u011fi<\/strong>: 13 analist &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecesi verdi, ortalama hedef 54,62 $<\/li>\n<li><strong>Yenilik\u00e7i pipeline<\/strong>: Kv7 mod\u00fclasyonu ve TYK2\/JAK1 inhibit\u00f6rleri dahil birden fazla platform<\/li>\n<li><strong>Kan\u0131tlanm\u0131\u015f ba\u015far\u0131<\/strong>: Nurtec ODT migren tedavisinde ba\u015far\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Zamanlama riskini azaltmak i\u00e7in birka\u00e7 ay boyunca k\u00fc\u00e7\u00fck al\u0131mlar yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in 11 Kas\u0131m kazan\u00e7lar\u0131n\u0131 izleyin<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: Dengeli bir portf\u00f6y i\u00e7in stabil temett\u00fc hisseleri ve endeks fonlar\u0131 ile dengeleyin<\/li>\n<\/ol>\n<p>Espiri: &#8220;BHVN ticareti klinik denemeleri izlemek gibidir\u2014g\u00fc\u00e7l\u00fc sinirlere ihtiyac\u0131n\u0131z var ve Faz 1 sonu\u00e7lar\u0131na asla t\u00fcm sermayenizi yat\u0131rmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE listeli hisseler ve par\u00e7al\u0131 hisse sunan bir platform se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;BHVN&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Do\u011fru sonu\u00e7lar i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014i\u015flem de\u011ferinin %1\u2019inden az olmas\u0131na dikkat edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmel ama d\u00fc\u015f\u00fck riskli<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong>\u2014sadece bir kimlik belgesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong>\u2014k\u00e2rlar\u0131n\u0131za birden fazla uygun y\u00f6ntemle eri\u015fin<\/li>\n<li><strong>E\u011fitim kaynaklar\u0131<\/strong>\u2014Pocket Option blogu ile i\u015flem yaparken \u00f6\u011frenin<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025\u2019te Biohaven: N\u00f6robilim \u0130novasyon Lideri<\/h2>\n<p>Biohaven, n\u00f6robilim biyoteknoloji alan\u0131nda en yenilik\u00e7i portf\u00f6ylerden biriyle sekt\u00f6rde hakimiyet kuruyor. Kan\u0131tlanm\u0131\u015f migren tedavileri Nurtec ODT ve Zavzpret\u2019in \u00f6tesinde, Parkinson, n\u00f6roenflamasyon ve nadir n\u00f6rolojik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler geli\u015ftiriyor. \u015eirket, 2025 Amerikan N\u00f6roloji Akademisi toplant\u0131s\u0131nda <strong>13 ara\u015ft\u0131rma \u00f6zeti<\/strong> sundu; Kv7 mod\u00fclasyonu, ekstrasel\u00fcler protein degradasyonu ve TRPM3 antagonizmas\u0131 gibi bir\u00e7ok ileri platformda bilimsel derinli\u011fini g\u00f6sterdi.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: Biohaven\u2019in Parkinson denemesi, beyin penetran TYK2\/JAK1 inhibit\u00f6r\u00fc ile n\u00f6roenflamasyonu hedefleyen ilk klinik \u00e7al\u0131\u015fma olup, d\u00fcnya \u00e7ap\u0131nda 10 milyondan fazla hasta i\u00e7in tedavide devrim yaratabilir.<\/p>\n"},"faq":[{"question":"Biohaven Ltd. (BHVN) hisseleri nereden al\u0131nabilir?","answer":"Biohaven hisseleri NYSE'de i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Biohaven hisseleri i\u00e7in en kritik tarih nedir?","answer":"11 Kas\u0131m 2025, Biohaven'in 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 kritik tarihtir ve genellikle hisse fiyat\u0131nda \u00f6nemli hareketler g\u00f6r\u00fcl\u00fcr."},{"question":"Biohaven hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici reddi, y\u00fcksek nakit t\u00fcketimi ve y\u00fcksek volatilite ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Biohaven hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 18-22 $, 2026'da 26-32 $, 2028'de 45-60 $ ve 2030'da 75-100+ $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar Biohaven hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %3-5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Biohaven Ltd. (BHVN) hisseleri nereden al\u0131nabilir?","answer":"Biohaven hisseleri NYSE'de i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Biohaven hisseleri i\u00e7in en kritik tarih nedir?","answer":"11 Kas\u0131m 2025, Biohaven'in 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 kritik tarihtir ve genellikle hisse fiyat\u0131nda \u00f6nemli hareketler g\u00f6r\u00fcl\u00fcr."},{"question":"Biohaven hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici reddi, y\u00fcksek nakit t\u00fcketimi ve y\u00fcksek volatilite ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Biohaven hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 18-22 $, 2026'da 26-32 $, 2028'de 45-60 $ ve 2030'da 75-100+ $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar Biohaven hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %3-5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T13:47:05+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-24T13:47:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\",\"name\":\"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-24T13:47:05+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/","og_locale":"tr_TR","og_type":"article","og_title":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T13:47:05+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-24T13:47:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/","name":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-24T13:47:05+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":344674,"slug":"how-to-buy-biohaven","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Biohaven Ltd. (BHVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biohaven\/"},"pt_AA":{"locale":"pt_AA","id":344673,"slug":"how-to-buy-biohaven","post_title":"Como comprar a\u00e7\u00f5es da Biohaven Ltd. (BHVN) - Investimento em a\u00e7\u00f5es da Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biohaven\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/344672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=344672"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/344672\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=344672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=344672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=344672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}